inactiv
airborn
pathogen
middl
east
respiratori
syndrom
merscov
viru
investig
control
laboratori
condit
two
set
climat
condit
use
experi
repres
common
offic
environ
rh
climat
condit
middl
eastern
region
viru
origin
rh
lower
temperatur
viru
demonstr
high
robust
strong
capabl
surviv
microorgan
remain
infecti
min
aerosolis
fortun
viru
decay
much
stronger
hot
dri
air
scenario
surviv
min
procedur
fig
microbi
rel
surviv
airborn
form
error
bar
repres
standard
deviat
least
measur
ov
pyankov
et
al
varieti
pathogen
microorgan
exist
air
could
potenti
transmitt
long
distanc
includ
influenza
viru
sar
viru
mycobacterium
tuberculosi
foot
mouth
deceas
mani
other
french
kelli
jone
clanci
sergeev
et
al
first
period
character
viral
capabl
surviv
airborn
form
appear
harper
harper
hemm
kool
winkler
hemm
winkler
kool
hood
author
report
interest
outcom
airborn
viru
behaviour
transmiss
effici
comprehens
studi
surviv
variou
strain
airborn
influenza
viru
recent
report
pyankov
pyankova
agranovski
show
presenc
virul
viru
even
min
aerosol
number
sar
outbreak
first
one
report
guangdong
provinc
china
novemb
mainli
affect
asian
region
took
live
achiev
fatal
rate
http
wwwwhointcsrsarscountri
tabl
outbreak
ignit
strong
research
interest
toward
identif
viru
transmiss
rout
atkinson
wein
spekreijs
bouma
koch
stegeman
tellier
exposur
effect
agranovski
et
al
hermann
zimmerman
kwon
swayn
transmiss
dynam
lipsitch
et
al
also
number
monitor
method
techniqu
develop
meet
demand
convent
agranovski
et
al
agranovski
et
al
agranovski
agranovski
reponen
willek
grinshpun
agranovski
myojo
braddock
agranovski
safatov
agafonov
pyankov
sergeev
hermann
et
al
rapid
detect
target
pathogen
ambient
air
agranovski
et
al
pyankov
et
al
usachev
usacheva
agranovski
comprehens
review
weber
stilianaki
produc
stage
describ
correspond
research
outcom
viru
inactiv
discuss
model
viru
transmiss
number
import
paramet
air
influenc
microorgan
surviv
deliveri
identifi
includ
air
temperatur
humid
microbi
resist
extern
physic
biolog
stress
solar
intens
other
septemb
sixth
new
type
coronaviru
identifi
saudi
arabia
call
middl
east
respiratori
syndrom
coronaviru
merscov
sinc
spread
patient
countri
gao
yao
yang
li
largest
outbreak
saudi
arabia
accord
case
unit
arab
emir
south
korea
choi
kim
cho
kim
peopl
infect
merscov
develop
sever
acut
respiratori
ill
includ
fever
cough
short
breath
mani
die
consid
possibl
respiratori
transmiss
azhar
et
al
well
transmiss
viabl
viru
settl
surfac
otter
et
al
import
investig
surviv
airborn
viru
aerosol
ambient
air
paper
present
result
investig
time
relat
inactiv
merscov
ambient
air
rang
climat
condit
repres
common
offic
environ
climat
condit
middl
eastern
region
viru
origin
experi
pathogen
microorgan
perform
high
contain
facil
biosafeti
level
human
betacoronaviru
emc
kindli
provid
erasmu
medic
center
rotterdam
netherland
merscov
isol
propag
cell
dulbecco
modifi
eagl
medium
dmem
gibco
supplement
fetal
calf
serum
gibco
mm
lglutamin
lonza
uml
penicillin
streptomycin
gibco
viru
stock
titrat
endpoint
titrat
cell
cell
inocul
tenfold
serial
dilut
viru
stock
dmem
supplement
fetal
calf
serum
mm
lglutamin
uml
penicillin
streptomycin
five
day
inocul
cytopath
effect
cpe
score
tissu
cultur
infect
dose
tcid
calcul
replic
spearmankarb
method
karber
spearman
laboratori
setup
use
experi
present
fig
viru
contain
suspens
prepar
aerosol
experiment
aerosol
chamber
collison
nebul
bgi
inc
usa
flowrat
lmin
hepafilt
compress
air
min
time
nebul
switch
experi
perform
two
set
paramet
air
repres
common
offic
environ
rh
climat
condit
middl
eastern
region
viru
origin
rh
minimis
gravit
aerosol
settlement
experi
previous
develop
rotat
aerosol
chamber
rac
pyankov
et
al
use
project
consist
drum
secur
stationari
axi
airseal
ball
bear
design
axi
enabl
host
pipelin
use
aerosol
charg
monitor
rac
place
biosafeti
compart
elimin
contamin
laboratori
air
virus
second
reason
use
compart
base
fact
requir
experiment
program
viru
surviv
ought
investig
elev
temperatur
repres
middl
eastern
climat
conditionsplac
origin
maximum
spread
investig
microorgan
achiev
constant
elev
temperatur
rac
entir
experiment
run
air
compart
heat
requir
valu
use
make
air
drawn
chamber
sampler
well
insul
rac
colder
ambient
air
laboratori
minim
temperatur
fluctuat
insid
rac
constant
air
humid
achiev
ad
requir
amount
steam
compart
air
humidifi
model
airoswiss
switzerland
air
temperatur
rel
humid
monitor
rac
accuraci
respect
entir
experiment
procedur
particl
concentr
size
distribut
insid
chamber
monitor
optic
particl
counter
model
aeronanotech
moscow
russia
min
increment
entir
run
monitor
viabl
viru
concentr
two
person
bioaerosol
sampler
agranovski
et
al
agranovski
et
al
charg
ml
collect
liquid
see
descript
sampl
aerosol
chamber
parallel
flow
rate
lmin
min
time
min
viru
aerosol
arrang
sampl
insid
chamber
extern
locat
sampler
standard
inlet
devic
agranovski
et
al
modifi
equip
pipe
enabl
hermet
connect
aerosol
chamber
fresh
pair
sampler
use
time
point
use
two
sampler
parallel
elimin
risk
repres
result
acquisit
due
potenti
random
human
error
technolog
fault
equip
chamber
equip
hepa
filter
makeup
air
line
ensur
escap
aerosol
laboratori
space
aerosolis
procedur
elimin
alien
particl
laboratori
space
possibl
reach
aerosol
chamber
monitor
virus
pump
counter
discharg
line
equip
hepa
filter
avoid
contamin
laboratori
space
airborn
virus
complet
sampl
time
interv
bioaerosol
sampler
disconnect
aliquot
collect
liquid
acquir
analys
endpoint
titrat
cell
five
day
inocul
cytopath
effect
cpe
score
tcid
calcul
replic
spearmankarb
method
aliquot
initi
viral
suspens
along
sampl
collect
liquid
acquir
time
period
also
analys
rtpcr
procedur
step
import
provid
inform
total
microbi
concentr
airborn
form
enabl
estim
viru
decay
take
account
gravit
settlement
air
dilut
relat
loss
undertak
procedur
rna
extract
analys
aliquot
use
qiaamp
viral
rna
minikit
qiagen
germani
accord
manufactur
instruct
realtim
reversetranscript
polymeras
chain
reaction
screen
assay
upstream
e
gene
upe
assay
perform
onestep
prpcr
kit
thermo
fisher
scientif
usa
reaction
contain
rna
x
reaction
buffer
nm
concentr
primer
upefwd
gcaacgcgcgattcagtt
primer
uperev
gcctctacacgggacccata
well
nm
probe
upeprb
fam
n
n
tamra
corman
et
al
oligonucleotid
synthes
src
vb
vector
russia
thermal
cycl
involv
min
follow
min
cycl
rotorgen
realtim
pcr
machin
corbett
research
australia
run
standard
dilut
titer
viru
stock
run
parallel
calcul
tcid
equival
sampl
dulbecco
modifi
eagl
medium
dmem
gibco
supplement
fetal
calf
serum
gibco
mm
lglutamin
lonza
uml
penicillin
streptomycin
gibco
use
collect
liquid
sampler
possibl
foam
format
minim
antifoam
agent
antifoam
sigma
chemic
compani
st
loui
ad
collect
liquid
volumetr
document
previou
public
use
recip
enabl
achiev
higher
viral
recoveri
rate
compar
collect
steril
water
agranovski
et
al
supplement
fetal
calf
serum
gibco
mm
lglutamin
lonza
uml
penicillin
streptomycin
gibco
five
day
inocul
cytopath
effect
cpe
score
tcid
calcul
replic
spearmankarb
method
ml
aliquot
viral
medium
place
collison
nebul
bgi
inc
usa
aerosol
lmin
compress
air
liquid
aerosol
rate
mlmin
follow
equat
use
estim
rel
microbi
inactiv
rmi
time
interv
first
term
right
hand
side
ratio
infect
virus
repres
tcid
valu
total
number
virus
infect
inactiv
obtain
rtpcr
time
interv
min
second
term
ratio
obtain
initi
condit
right
begin
experi
min
mention
use
result
obtain
rtpcr
enabl
account
potenti
loss
due
gravit
settlement
wall
rac
consid
result
repres
time
relat
presenc
total
airborn
viru
infect
inactiv
rac
decreas
valu
time
could
relat
particl
settlement
wall
ratio
tcid
total
pcr
count
time
experi
relat
ratio
begin
run
clearli
repres
viral
surviv
particular
point
time
first
notic
sampler
involv
experiment
run
demonstr
excel
intersampl
variat
discrep
vast
major
run
basi
follow
result
repres
averag
two
number
obtain
two
person
sampler
oper
parallel
experiment
run
result
measur
particl
size
distribut
rac
shown
fig
initi
concentr
viru
contain
particl
quit
common
repres
aerosol
composit
produc
collison
nebul
show
approxim
ratio
viral
particl
liquid
carrier
droplet
size
repres
common
environment
scenario
virus
usual
travel
larger
carrier
air
stream
shift
curv
obtain
min
process
run
temperatur
rh
toward
smaller
particl
size
indic
rather
minor
evapor
droplet
air
condit
much
signific
chang
observ
experi
undertaken
temperatur
rh
seen
neglig
amount
particl
diamet
larger
observ
vast
major
particl
remain
air
one
hour
experi
condit
smaller
fig
demonstr
result
determin
airborn
live
viru
concentr
tcid
along
number
total
virus
obtain
rtpcr
differ
time
period
per
millilitr
sampler
collect
liquid
seen
total
number
virus
decreas
significantli
first
fifteen
minut
experi
becom
steadi
rest
run
minor
decreas
g
remain
minut
procedur
similar
trend
observ
live
merscov
viru
rh
experiment
condit
major
inactiv
occur
first
fifteen
minu
experi
inactiv
rate
becam
smaller
addit
loss
tcid
rest
experi
much
signific
inactiv
detect
experi
undertaken
rh
first
min
inactiv
curv
trend
similar
curv
obtain
lower
temperatur
scenario
howev
went
steepli
next
min
loos
addit
tcid
end
min
run
almost
live
particl
remain
air
tcid
ml
microbi
rel
inactiv
estim
eq
experiment
condit
shown
fig
seen
curv
show
similar
trend
first
min
experi
depart
significantli
reach
ov
pyankov
et
al
journal
aerosol
scienc
differ
around
end
min
run
wellexpect
time
relat
influenc
climat
condit
aerosol
paramet
shown
fig
one
observ
number
concentr
obtain
particl
counter
decreas
significantli
min
experiment
run
especi
experi
undertaken
hot
air
environ
addit
distinct
shift
size
distribut
curv
toward
smaller
aerosol
size
particularli
notic
climat
condit
repres
middl
eastern
region
howev
take
account
steadi
timerel
rtpcr
result
reflect
signific
reduct
airborn
viru
presenc
air
one
could
conclud
particl
concentr
decreas
minim
reason
visual
effect
base
intens
particl
evapor
correspond
diamet
decreas
make
aerosol
invis
optic
counter
basi
conclud
rac
perform
satisfactori
enabl
ensur
minim
loss
total
airborn
viral
concentr
entir
durat
experiment
run
result
merscov
viru
inactiv
differ
climat
condit
obtain
viru
concentr
initi
suspens
use
aerosol
around
gml
base
experiment
seri
number
repres
averag
microbi
concentr
identifi
initi
suspens
throughout
entir
project
run
along
standard
deviat
result
aerosolis
loss
due
physic
microbi
stress
settlement
wall
pipelin
clearli
seen
fig
howev
rather
minor
exceed
loss
document
previous
pyankov
et
al
viru
demonstr
rel
high
robust
airborn
form
compar
influenza
strain
investig
pyankov
et
al
similar
air
paramet
rh
surviv
rate
vari
strain
acalifornia
strain
coronaviru
demonstr
surviv
around
howev
surviv
decreas
dramat
hot
dri
air
condit
leav
around
live
speci
one
hour
oper
identifi
climat
relat
signific
airborn
viru
inactiv
singl
factor
anova
test
p
conduct
compar
microbi
surviv
differ
climat
condit
variou
experiment
time
notic
regardless
fact
result
differ
climat
condit
present
fig
look
quit
differ
almost
begin
experi
statist
signific
variat
detect
first
min
oper
contrast
result
obtain
min
experiment
run
demonstr
statist
signific
differ
microbi
decay
differ
climat
condit
sampl
time
relat
inactiv
pathogen
strain
merscov
airborn
form
variou
climat
condit
investig
found
temperatur
viru
demonstr
rel
high
compar
influenza
strain
surviv
live
particl
remain
air
min
aerosolis
inactiv
temperatur
fortun
much
effici
activ
viru
detect
complet
min
run
result
demonstr
even
hot
dri
climat
condit
relev
middl
eastern
region
viru
origin
strain
abl
surviv
quit
long
time
period
could
potenti
spread
result
respiratori
transmiss
